Benecta™ is comprised of chitooligosaccharides produced from high quality chitin derived from crustacean exoskeletons and has been developed to help the body maintain a healthy extra-cellular environment. Benecta™ supports the human body's natural regenerative properties by helping the body respond and heal.
Founded in 2005, Genis is a privately held biotechnology company located in Iceland. The company's focus is on the discovery, development and commercialization of crustacean derived biopharmaceuticals, supplements and medical devices which can be applied in the treatment of a broad spectrum of inflammatory and degenerative diseases.
The company's team of scientists have been carrying out research on the production of chitin, chitosan and chitin-derived oligosaccharides for therapeutic applications for two decades